Literature DB >> 18672183

Hyperlipidemia in the elderly.

Nicole Ducharme1, Rani Radhamma.   

Abstract

People are now living longer, largely because of a combination of falling rates of fertility and mortality, thus producing a greater proportion of older people in society. Thirty times more centenarians were alive in 2000 than in 1900, and the population growth in the elderly segment of society is expected to continue at an exponential rate. Vascular disease is responsible for more than a quarter of all deaths worldwide. More than 80% of individuals who die of coronary heart disease are older than 65 years. Although a myocardial infarction may be perceived as fatal, heart attacks do not always lead to death but to conditions such as congestive heart failure, ischemic cardiomyopathy, and angina, which greatly impact quality of life. These issues are only a few that must be contemplated when considering the clinical and economic effects of preventive therapies in the elderly population.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18672183     DOI: 10.1016/j.cger.2008.03.007

Source DB:  PubMed          Journal:  Clin Geriatr Med        ISSN: 0749-0690            Impact factor:   3.076


  5 in total

1.  Statin treatment for older adults: the impact of the 2013 ACC/AHA cholesterol guidelines.

Authors:  Yitzchak Weinberger; Benjamin H Han
Journal:  Drugs Aging       Date:  2015-02       Impact factor: 3.923

Review 2.  Primary prevention of cardiovascular disease with statins in the elderly.

Authors:  Zeljko Reiner
Journal:  Curr Atheroscler Rep       Date:  2014-07       Impact factor: 5.113

Review 3.  Pharmacoeconomics and aging.

Authors:  Silvia Bustacchini; Andrea Corsonello; Graziano Onder; Enrico Eugenio Guffanti; Flavio Marchegiani; Angela Marie Abbatecola; Fabrizia Lattanzio
Journal:  Drugs Aging       Date:  2009-12       Impact factor: 3.923

Review 4.  Statins for Primary Prevention of Cardiovascular Disease in Elderly Patients: Systematic Review and Meta-Analysis.

Authors:  Monica Teng; Liang Lin; Ying Jiao Zhao; Ai Leng Khoo; Barry R Davis; Quek Wei Yong; Tiong Cheng Yeo; Boon Peng Lim
Journal:  Drugs Aging       Date:  2015-08       Impact factor: 3.923

5.  Chinese herbal medicine for hypertension complicated with hyperlipidemia: A protocol for a systematic review and meta-analysis.

Authors:  Yinan Liu; Yiqing Liu; Jing Yang; Xue Wang; Chengkui Xiu; Yanhong Hu; Dan Wu; Ye Wu; Yan Lei
Journal:  Medicine (Baltimore)       Date:  2021-02-12       Impact factor: 1.817

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.